HALO logo
halo search icon
NewAmsterdam Pharma Company N.V.

US$35.75

Price Change Indicator
2.03 (6.02%)
NewAmsterdam Pharma Company N.V.
NAMS · NAS

NewAmsterdam Pharma Company N.V.

Start Trading NAMS for Free

US$35.75

Price Arrow2.03 (6.02%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Earnings MomentumHALO Momentum
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

NewAmsterdam Pharma Company N.V. Overview

NAMS Health Scores

Short Term

Mean Reversion

Very Weak

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About NAMS

icon

Website

NewAmsterdam Pharma Company N.V.

icon

Telephone

icon

Address

Description

NewAmsterdam Pharma Co. NV is a clinical-stage biopharmaceutical company, which engages in the development of oral, non-statin medicine for patients at high risk of cardiovascular disease with residual elevation of low-density lipoprotein cholesterol. Its lead product candidate, Obicetrapib, is a next-generation, oral, low-dose cholesteryl ester transfer protein inhibitor, which will be used to prevent major adverse cardiovascular events. The company was founded on June 10, 2022 and is headquartered in Naarden, the Netherlands.

NAMS Price Chart

Key Stats

Market Cap

US$3.94B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 16.78 - 42.21

Trade Value (12mth)

US$7,518,120.00

1 week

-4.85%

1 month

3.82%

YTD

-4.2%

1 year

82.17%

All time high

42.21

Key Fundamentals

EPS 3 yr Growth

44.20%

EBITDA Margin

NaN%

Operating Cashflow

-$148m

Free Cash Flow Return

-20.50%

ROIC

-28.30%

Interest Coverage

0.00

Quick Ratio

7.90

Other Data

Shares Outstanding (Fully Diluted)

122m

HALO Sector

Other Finance

Next Company Report Date

03-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

NAMS Announcements

Latest Announcements

DateAnnouncements
07 May 26
07 May 26
07 May 26
25 April 26
25 April 26

NAMS Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-2.15-2.56-1.72locklocklock
EPS (Fully Diluted)
 $locklocklocklock-2.15-2.56-1.72locklocklock
Growth
 %locklocklocklock-80.5-18.932.8locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of NewAmsterdam Pharma Company N.V. (NAMS:NAS)?
Halo FAQ
The current share price of NewAmsterdam Pharma Company N.V. (NAMS:NAS) is USD$35.75.
What is the 52-week high share price for NewAmsterdam Pharma Company N.V. (NAMS:NAS)?
Halo FAQ
The 52-week high share price for NewAmsterdam Pharma Company N.V. (NAMS:NAS) is USD$42.21.
What is the 52-week low share price for NewAmsterdam Pharma Company N.V. (NAMS:NAS)?
Halo FAQ
The 52-week low share price for NewAmsterdam Pharma Company N.V. (NAMS:NAS) is USD$16.78.
What is the dividend yield for NewAmsterdam Pharma Company N.V. (NAMS:NAS)?
Halo FAQ
NewAmsterdam Pharma Company N.V. (NAMS:NAS) does not pay a dividend.
What was NewAmsterdam Pharma Company N.V. (NAMS:NAS) last dividend payment?
Halo FAQ
NewAmsterdam Pharma Company N.V. (NAMS:NAS) does not pay a dividend.
What is the franking level for NewAmsterdam Pharma Company N.V. (NAMS:NAS)?
Halo FAQ
NewAmsterdam Pharma Company N.V. (NAMS:NAS) has a franking level of 0.00%.
In which sector is NewAmsterdam Pharma Company N.V. (NAMS:NAS) classified?
Halo FAQ
NewAmsterdam Pharma Company N.V. (NAMS:NAS) is classified in the Other Finance.
What is the price-to-earnings (P/E) ratio for NewAmsterdam Pharma Company N.V. (NAMS:NAS)?
Halo FAQ
The current P/E ratio for NewAmsterdam Pharma Company N.V. (NAMS:NAS) is 0.00.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial